May 22, 2026
Analyst Bio:
Rosenblatt is “pounding the table” on shares of Imax (IMAX) into the summer movie season. The stock’s recent selloff does not reflect the strength of the film slate, the company’s active management of its film portfolio to maximize box office, and the inherent leverage in its model that is driving margins to record levels, the analyst tells investors in a research note. In addition, the Wall Street Journal reported that Imax is exploring a sale, adds the firm. The stock in premarket trading is up 14%, or $4.62, to $38.50.
